Skip to search formSkip to main contentSkip to account menu

Everolimus:Mass:Pt:Dose:Qn

Known as: Everolimus Dose, Everolimus:Kütle:Zml?:Doz:Kant, Everoliimus:Mass:Pt:Dose:Qn 
National Institutes of Health

Related topics

Related topics

4 relations
DosageDrug dose (for transmitting doses for pharmacokinetics)Mass, a measure of quantity of mattereverolimus

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Abstract P1-19-43: Palbociclib-fulvestrant (PALBO-FUL) and everolimus -exemestane (EVE-EXE) for second line hormonal treatment (HT) of metastatic breast cancer (MBC) with lobular histology: A…
2017
2017
Everolimus zur Therapie der fortgeschrittenen steroidresistenten chronischen Graft-versus-Host Erkrankung nach allogener hämatopoetischer Stammzelltransplantation
Die Behandlung der chronischen GvHD (cGvHD) stellt auch nach langjahriger Etablierung der allogenen Stammzelltransplantation eine… 
2016
2016
Cabozantinib Tops Everolimus in Advanced RCC, Regardless of MET Expression
Expression of MET as measured by immunohistochemistry was not associated with any difference in the performance of cabozantinib… 
2016
2016
Adding Everolimus Doubles PFS in AI-Resistant Metastatic Breast Cancer
The addition of everolimus to fulvestrant was associated with more than a doubling of progression-free survival in women with… 
2014
2014
Progress with Drug-Eluting Stent Technology from Early to New Generation Devices
__Abstract__ Percutaneous coronary interventions (PCI) are among the most frequently performed medical interventions… 
2005
2005
Drug Eluting Stent Implantation for High Risk Patients and Novel Technologies in Percutaneous Coronary Intervention
textabstractPercutaneous coronary intervention is a major treatment strategy for patients with coronary artery disease, and…